Journal of Cardiothoracic and Vascular Anesthesia
Original ArticleContinuous Magnesium Infusion to Prevent Atrial Fibrillation After Cardiac Surgery: A Sequential Matched Case-Controlled Pilot Study
Section snippets
Study Design
The authors performed an investigator-initiated, sequential matched case-controlled pilot study in the multidisciplinary ICU of Austin Hospital, a tertiary care hospital in Melbourne, Australia. The intervention phase of the study was conducted from September 25, 2017 to June 22, 2018. The study was approved by the Human Research Ethics Committee of Austin Health (HREC reference number LNR/17/Austin/416) as a unit practice change protocol with a waiver for informed consent. The study was
Patient Characteristics
The authors enrolled 99 patients in the intervention group and matched them with 99 patients in the historical control group. The flowchart of the study enrollment of the intervention group patients and the selection process of the historical control group are demonstrated in Figure 2. The patient groups had similar baseline characteristics, except for a lower cardiac index at admission to the ICU in the intervention group (Table 1).
Magnesium Delivery in the Intervention Group
In the intervention group, 71 patients (71.7%) received a
Key Findings
In this single-center matched case-control sequential pilot study, the authors observed a reduced occurrence of newly diagnosed postoperative AF after cardiac surgery in patients who received a postoperative strategy of bolus loading and continuous intravenous magnesium delivery to target a magnesium level between 1.5 and 2 mmol/L compared with a matched pre-intervention control group. Moreover, although the study intervention resulted in a significant increase in serum magnesium levels as
Conclusion
The authors conducted a sequential matched case-controlled pilot study to assess the impact of a continuous magnesium delivery strategy targeting a magnesium level between 1.5 and 2.0 mmol/L. The authors found that such a strategy was associated with a significant decrease in the incidence of AF after cardiac surgery and was free of major complications. These observations provide the rationale for testing the efficacy of this magnesium delivery protocol in future randomized controlled studies.
Conflict of Interest
Declarations of interest: none.
References (45)
- et al.
The persistent problem of new-onset postoperative atrial fibrillation: A single-institution experience over 2 decades
J Thorac Cardiovasc Surg
(2011) - et al.
Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery
J Am Coll Cardiol
(2008) - et al.
Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: The Amiodarone Reduction in Coronary Heart (ARCH) trial
J Am Coll Cardiol
(1999) - et al.
A beta-blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery
J Cardiothorac Vasc Anesth
(2001) - et al.
Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: The beta-Blocker Length Of Stay (BLOS) study
Am Heart J
(2003) - et al.
Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery
J Cardiothorac Vasc Anesth
(1994) - et al.
Effects of magnesium sulfate on cardiac conduction and refractoriness in humans
J Am Coll Cardiol
(1986) - et al.
Hypomagnesemia is common following cardiac surgery
J Cardiothorac Vasc Anesth
(1991) - et al.
Effect of intravenous magnesium sulfate on supraventricular tachycardia
Am J Cardiol
(1989) - et al.
Magnesium status and magnesium therapy in cardiac surgery: A systematic review and meta-analysis focusing on arrhythmia prevention
J Crit Care
(2017)
Pharmacokinetics of magnesium bolus therapy in cardiothoracic surgery
J Cardiothorac Vasc Anesth
Magnesium supplementation: Pharmacokinetics in cardiac surgery patients with normal renal function
J Crit Care
Development and validation of a score to identify cardiac surgery patients at high risk of prolonged mechanical ventilation
J Cardiothorac Vasc Anesth
Acute risk change (ARC) identifies outlier institutions in perioperative cardiac surgical care when the standardized mortality ratio cannot
Br J Anaesth
Magnesium sulfate therapy after cardiac surgery: A before-and-after study comparing strategies involving bolus and continuous infusion
Crit Care Resusc
The efficacy of supplemental magnesium in reducing atrial fibrillation after coronary artery bypass grafting
Ann Thorac Surg
Prophylaxis of atrial fibrillation with magnesium sulfate after coronary artery bypass grafting
Ann Thorac Surg
Perioperative magnesium supplementation to prevent atrial fibrillation after off-pump coronary artery surgery: A randomized controlled study
J Cardiothorac Vasc Anesth
Intravenous magnesium sulfate prophylaxis for atrial fibrillation after coronary artery bypass surgery
J Thorac Cardiovasc Surg
Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation
Ann Thorac Surg
Mechanism of plasma catecholamine increases during coronary artery bypass and valve procedures
J Thorac Cardiovasc Surg
Levels of circulating norepinephrine and epinephrine before, during, and after cardiopulmonary bypass in man
J Thorac Cardiovasc Surg
Cited by (4)
Interventions to prevent postoperative atrial fibrillation in Dutch cardiothoracic centres: a survey study
2024, Netherlands Heart JournalEffect of Magnesium Sulfate in Prevention of Postoperative Atrial Fibrillation Arrhythmia among Candidates of CABG Surgery with Abnormal P-wave Duration
2022, Journal of Kerman University of Medical Sciences
Financial support for this study was received from the Anesthesia and Intensive Care Trust Fund, Austin Hospital. The funding source had no involvement in study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the article for publication.